Document Detail


Nutrition in oncologic patients during antiblastic treatment.
MedLine Citation:
PMID:  23276913     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Cancer may induce weight loss and cachexia, and cancer treatment may contribute to nutritional impairment. Here, we review the literature on the mechanisms of cancer cachexia and the pharmacological interventions both in use in clinical practice and currently under development. Based on this analysis, several nutritional proposals for cancer patients are suggested and the importance of good nutritional status in candidates for hematopoietic stem cell transplantation is highlighted.
Authors:
Massimiliano Berretta; Mariagrazia Michieli; Raffaele Di Francia; Alessandro Cappellani; Maurizio Rupolo; Fabio Galvano; Rossella Fisichella; Salvatore Berretta; Umberto Tirelli
Related Documents :
21475793 - Reduced transcription of the smad4 gene during pulmonary carcinogenesis in idiopathic p...
23440423 - Regulation of lung cancer metastasis by klf4-numb-like signaling.
22052623 - Role of fdg-pet as a biological marker for predicting the hypoxic status of tongue cancer.
Publication Detail:
Type:  Journal Article     Date:  2013-01-01
Journal Detail:
Title:  Frontiers in bioscience : a journal and virtual library     Volume:  18     ISSN:  1093-4715     ISO Abbreviation:  Front. Biosci.     Publication Date:  2013  
Date Detail:
Created Date:  2013-01-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9709506     Medline TA:  Front Biosci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  120-32     Citation Subset:  IM    
Affiliation:
Department of Medical Oncology, Centro di Riferimento Oncologico, National Cancer Institute, Aviano, Via Franco Gallini 2, 33081 Aviano (PN), Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Platelet-derived growth factor signaling in mesenchymal cells.
Next Document:  Integrating leptin and cAMP signalling pathways in triple-negative breast cancer cells.